Filing Details
- Accession Number:
- 0001179110-12-004065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-02 17:16:25
- Reporting Period:
- 2012-02-29
- Filing Date:
- 2012-03-02
- Accepted Time:
- 2012-03-02 17:16:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1383841 | B Robert Hance | 100 Abbott Park Road Abbott Park IL 60064-6400 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2012-02-29 | 46,400 | $46.34 | 199,096 | No | 4 | M | Direct | |
Common Shares Without Par Value | Acquisiton | 2012-02-29 | 57,000 | $44.16 | 256,096 | No | 4 | M | Direct | |
Common Shares Without Par Value | Acquisiton | 2012-02-29 | 26,000 | $48.76 | 282,096 | No | 4 | M | Direct | |
Common Shares Without Par Value | Acquisiton | 2012-02-29 | 47,547 | $51.91 | 329,643 | No | 4 | M | Direct | |
Common Shares Without Par Value | Acquisiton | 2012-02-29 | 3,050 | $33.23 | 332,693 | No | 4 | M | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 1,776 | $57.04 | 330,917 | No | 4 | F | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 10,133 | $57.04 | 320,784 | No | 4 | F | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 6,300 | $56.70 | 314,484 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 373 | $56.70 | 314,111 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 18,100 | $56.71 | 296,011 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 100 | $56.71 | 295,911 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 5,873 | $56.71 | 290,038 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 227 | $56.71 | 289,811 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 400 | $56.72 | 289,411 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 4,112 | $56.72 | 285,299 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 900 | $56.73 | 284,399 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 6,550 | $56.73 | 277,849 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 8,600 | $56.74 | 269,249 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 7,450 | $56.74 | 261,799 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 7,627 | $56.75 | 254,172 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 400 | $56.75 | 253,772 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 6,500 | $56.75 | 247,272 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 100 | $56.75 | 247,172 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 200 | $56.76 | 246,972 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 6,176 | $56.76 | 240,796 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 5,100 | $56.77 | 235,696 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2012-02-29 | 9,900 | $56.77 | 225,796 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Disposition | 2012-02-29 | 46,400 | $0.00 | 46,400 | $46.34 |
Common Shares | Option (right to buy) | Disposition | 2012-02-29 | 57,000 | $0.00 | 57,000 | $44.16 |
Common Shares | Option (right to buy) | Disposition | 2012-02-29 | 26,000 | $0.00 | 26,000 | $48.76 |
Common Shares | Option (right to buy) | Disposition | 2012-02-29 | 47,547 | $0.00 | 47,547 | $51.91 |
Common Shares | Option (right to buy) | Disposition | 2012-02-29 | 3,050 | $0.00 | 3,050 | $33.23 |
Common Shares | Option (right to buy) | Acquisiton | 2012-02-29 | 1,776 | $0.00 | 1,776 | $57.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2008-02-18 | 2015-02-17 | No | 4 | M | Direct |
0 | 2009-02-17 | 2016-02-16 | No | 4 | M | Direct |
0 | 2009-12-29 | 2016-12-28 | No | 4 | M | Direct |
0 | 2008-03-05 | 2013-02-13 | No | 4 | M | Direct |
0 | 2006-02-14 | 2013-02-13 | No | 4 | M | Direct |
1,776 | 2012-08-30 | 2013-02-13 | No | 4 | A | Direct |
Footnotes
- Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3.
- Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.